ZTE veranstaltet Global Summit & User Congress 2025 in Mailand unter dem Motto „Expanding Intelligence, Creating Possibilities”

DuraServ Announces Expansion of West Coast Solutions

ALLOSOURCE® ANNOUNCES RESEARCH FEATURING ITS PROPRIETARY VIATRUE® CRYOPRESERVATION PROCESS IS BEING PRESENTED AT THE 18TH INTERNATIONAL CARTILAGE REGENERATION & JOINT PRESERVATION SOCIETY WORLD CONGRESS

El condado de Miami-Dade declara el 10 de octubre como “El Día de los Supermercados Sedano’s”

Alamar Biosciences bringt NULISAqpcr™ BD-pTau217 Assay auf den Markt: Durchbruch beim nicht-invasiven, hirnspezifischen Biomarker-Nachweis für die Alzheimer-Forschung

123Invent Inventor Develops New Bed Liner for Pickup Trucks (NAM-829)

Sedano’s Supermarkets Receives Miami-Dade County Proclamation Declaring October 10 as “Sedano’s Supermarkets Day”

On World Mental Health Day, NAMI Announces New Scientific Advisory Council to Advance Hope Through Research

NAIFA-Iowa honors Merle Miller with annual prestigious award

Bybit ottiene la prima licenza di operatore di piattaforma di asset virtuali degli Emirati Arabi Uniti dalla Securities and Commodities Authority

Nexans Innovation Summit 2025 Highlights Transmission as the Defining Enabler of Global Electrification

Prudential Advisors Opens New Office in Midtown Manhattan

Utility Award Winners Honored for Excellence in Customer Experience and Advertising Innovation at 2025 E Source Forum

National Press Club Statement on Dong Yuyu’s Appeal Extension

AGL Investor News: Rosen Law Firm Encourages agilon health, inc. Investors to Inquire About Securities Class Action Investigation – AGL

123Invent Inventor Develops Portable Power Supply & Flag Light (CTK-1914)

NFPA and State Farm® Team Up for Ninth Year to Promote Fire Prevention Week Nationwide

CRMT Investor News: Rosen Law Firm Encourages America’s Car-Mart, Inc. Investors to Inquire About Securities Class Action Investigation – CRMT

FTNT Investors Have Opportunity to Lead Fortinet, Inc. Securities Fraud Lawsuit

Alamar Biosciences lance le test NULISAqpcr™ BD-pTau217 : une avancée dans la détection non invasive de biomarqueurs spécifiques au cerveau pour la recherche sur la maladie d’Alzheimer